PPA helps two million Americans in a year

16 April 2006

The USA's Partnership for Prescription Assistance (PPA), a national program sponsored by America's research-based drugmakers to help patients in need access prescription medicines, this month commemorated its one-year anniversary by launching the first annual "Patient Assistance Day" and enhancing its services. Educational activities took place across the country to raise awareness of, and help boost, enrollment in patient assistance programs. The PPA has helped more than two million uninsured and underinsured patients, but millions more are expected to benefit.

"The PPA is an enormous success," said Billy Tauzin, chief executive of the Pharmaceutical Research and Manufacturers of America. "However, we realize that millions more need assistance. That is why we are doing everything we can to improve the PPA so we can continue to identify and assist patients in need," he added.

The newest feature of the scheme connects patients with free health clinics in their community. Over its first year of operations, the PPA learned that access to a physician was often the greatest obstacle to completing applications for prescription assistance programs. It hopes that the free clinic database will alleviate that challenge for millions of patients in need.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight